This study involves the treatment of cognitive impairment secondary to moderate to severe
brain injury using central thalamic deep brain stimulation. Although all patients will
receive stimulation continuously through a surgically implanted pacemaker-like device, half
of the patients will have the device deactivated during a blinded assessment phase. The
device will be reactivated following this assessment and patients will have the option to
continue stimulation in an open-label continuation.